Basolateral uptake of nucleosides by sertoli cells is mediated primarily by equilibrative nucleoside transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 346, Issue 1, 2013, Pages 121-129

  Klein, David M ^a   Evans, Kristen K ^b   Hardwick, Rhiannon N ^a   Dantzler, William H ^b   Wright, Stephen H ^b   Cherrington, Nathan J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; NITROBENZYLTHIOINOSINE; NUCLEOSIDE; NUCLEOSIDE TRANSPORTER; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; URIDINE; ZIDOVUDINE;

ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BLOOD TESTIS BARRIER; CELL CULTURE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DESIGN; DRUG TRANSPORT; EX VIVO STUDY; HUMAN; HUMAN TISSUE; MOLECULAR MECHANICS; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; SEMINIFEROUS TUBULE; SERTOLI CELL; TESTIS;

ADULT; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-TESTIS BARRIER; CELL MEMBRANE; CELL POLARITY; CELLS, CULTURED; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; HUMANS; MALE; MEMBRANE TRANSPORT MODULATORS; MICE; NUCLEOSIDES; PROTEIN TRANSPORT; RATS; REVERSE TRANSCRIPTASE INHIBITORS; SEMINIFEROUS TUBULES; SERTOLI CELLS; URIDINE;

EID: 84879288959     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.203265     Document Type: Article

References (41)

1. Abd-Elfattah A.S., Ding M, Jessen M.E., and Wechsler AS (2012) On-pump inhibition of es-ENT1 nucleoside transporter and adenosine deaminase during aortic cross-clamping entraps intracellular adenosine and protects against reperfusion injury: role of adenosine A1 receptor. J Thorac Cardiovasc Surg 144:243-249.
2. Anderson PL, Noormohamed SE, Henry K, Brundage R.C., Balfour HH, Jr, and Fletcher CV (2000) Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection. Pharmacotherapy 20:917-922.
3. Augustine LM, Markelewicz RJ, Jr, Boekelheide K, and Cherrington NJ (2005) Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier. Drug Metab Dispos 33:182-189.
4. Baldwin SA, Beal PR, Yao S.Y., King AE, Cass CE, and Young JD (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447:735-743.
5. Byrn RA and Kiessling AA (1998) Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir. J Reprod Immunol 41: 161-176.
6. Caballero I, Parrilla I, Almiñana C, del Olmo D, Roca J, Martínez EA, and Vázquez JM (2012) Seminal plasma proteins as modulators of the sperm function and their application in sperm biotechnologies. Reprod Domest Anim 47 (suppl 3):12-21.
7. Cao YJ, Caffo B, Choi L., Radebaugh CL, Fuchs EJ, and Hendrix CW (2008) Non-invasive quantitation of drug concentration in prostate and seminal vesicles: improvement and validation with desipramine and aspirin. J Clin Pharmacol 48: 176-183.
8. Cornwall GA (2009) New insights into epididymal biology and function. Hum Reprod Update 15:213-227.
9. Dahl V, Josefsson L, and Palmer S (2010) HIV reservoirs, latency, and reactivation: prospects for eradication. Antiviral Res 85:286-294.
10. Dumond JB, Reddy YS, Troiani L, Rodriguez J.F., Bridges AS, Fiscus SA, Yuen GJ, Cohen M.S., and Kashuba AD (2008) Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men. J Acquir Immune Defic Syndr 48:156-162.
11. Else LJ, Taylor S, Back D.J., and Khoo SH (2011) Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract. Antivir Ther 16:1149-1167.
12. Errasti-Murugarren E., Fernández-Calotti P, Veyhl-Wichmann M, Diepold M, Pinilla-Macua I, Pérez-Torras S, Kipp H, Koepsell H, and Pastor-Anglada M (2012) Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia. Mol Pharmacol 82:59-67.
13. Fernández-Calotti P.X., Colomer D, and Pastor-Anglada M (2011) Translocation of nucleoside analogs across the plasma membrane in hematologic malignancies. Nucleosides Nucleotides Nucleic Acids 30:1324-1340.
14. Gray JH, Owen RP, and Giacomini KM (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447:728-734.
15. Griffiths M, Yao SY, Abidi F, Phillips S.E., Cass CE, Young JD, and Baldwin SA (1997) Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem J 328: 739-743.
16. Groves CE, Evans KK, Dantzler W.H., and Wright SH (1994) Peritubular organic cation transport in isolated rabbit proximal tubules. Am J Physiol 266:F450-458.
17. Ishida K, Fukao M, Watanabe H., Taguchi M, Miyawaki T, Matsukura H., Uemura O, Zhang Z, Unadkat J.D., and Hashimoto Y (2013) Effect of salt intake on bioavailability of mizoribine in healthy Japanese males. Drug Metab Pharmcokinet 28:75-80.
18. Kato R, Maeda T, Akaike T., and Tamai I (2005) Nucleoside transport at the blood-testis barrier studied with primary-cultured sertoli cells. J Pharmacol Exp Ther 312:601-608.
19. Kato R, Maeda T, Akaike T., and Tamai I (2009) Characterization of nucleobase transport by mouse Sertoli cell line TM4. Biol Pharm Bull 32:450-455.
20. Kong W, Engel K, and Wang J (2004) Mammalian nucleoside transporters. Curr Drug Metab 5:63-84.
21. Leung GP, Ward JL, Wong P.Y., and Tse CM (2001) Characterization of nucleoside transport systems in cultured rat epididymal epithelium. Am J Physiol Cell Physiol 280:C1076-C1082.
22. Li N, Wang T, and Han D (2012) Structural, cellular and molecular aspects of immune privilege in the testis. Front Immunol 3:152.
23. Lu DY, Li Y, Bi Z.W., Yu HM, and Li XJ (2008) Expression and immunohistochemical localization of aquaporin-1 in male reproductive organs of the mouse. Anat Histol Embryol 37:1-8.
24. Lu H, Chen C, and Klaassen C (2004) Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice. Drug Metab Dispos 32:1455-1461.
25. Malo C and Berteloot A (1991) Analysis of kinetic data in transport studies: new insights from kinetic studies of Na(1)-D-glucose cotransport in human intestinal brush-border membrane vesicles using a fast sampling, rapid filtration apparatus. J Membr Biol 122:127-141.
26. Mital P, Hinton BT, and Dufour JM (2011) The blood-testis and blood-epididymis barriers are more than just their tight junctions. Biol Reprod 84:851-858.
27. Molina-Arcas M., Trigueros-Motos L, Casado F.J., and Pastor-Anglada M (2008) Physiological and pharmacological roles of nucleoside transporter proteins. Nucleosides Nucleotides Nucleic Acids 27:769-778.
28. Mruk DD and Cheng CY (2011) An in vitro system to study Sertoli cell blood-testis barrier dynamics. Methods Mol Biol 763:237-252.
29. Nishimura T, Chishu T, Tomi M., Nakamura R, Sato K, Kose N., Sai Y, and Nakashima E (2012) Mechanism of nucleoside uptake in rat placenta and induction of placental CNT2 in experimental diabetes. Drug Metab Pharmcokinet 27: 439-446.
30. Olson DP, Scadden DT, D'Aquila RT, and De Pasquale MP (2002) The protease inhibitor ritonavir inhibits the functional activity of the multidrug resistance related-protein 1 (MRP-1). AIDS 16:1743-1747.
31. Pastor-Anglada M., Cano-Soldado P, Molina-Arcas M, Lostao MP, Larráyoz I, Martínez-Picado J, and Casado FJ (2005) Cell entry and export of nucleoside analogues. Virus Res 107:151-164.
32. Pelletier RM (2011) The blood-testis barrier: the junctional permeability, the proteins and the lipids. Prog Histochem Cytochem 46:49-127.
33. Pereira AS, Smeaton LM, Gerber J.G., Acosta EP, Snyder S, Fiscus SA, Tidwell R.R., Gulick RM, Murphy RL, and Eron JJ, Jr (2002) The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850). J Infect Dis 186:198-204.
34. Lowe SH, van Leeuwen E, Droste JA, van der Veen F, Reiss P, Lange JM, Burger DM, Repping S, and Prins JM (2007) Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimen. Ther Drug Monit 29:566-570.
35. 1-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914-2927.
36. Rodríguez-Mulero S., Errasti-Murugarren E, Ballarín J, Felipe A., Doucet A, Casado FJ, and Pastor-Anglada M (2005) Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes. Kidney Int 68:665-672.
37. Takano M, Kimura E, Suzuki S., Nagai J, and Yumoto R (2010) Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures. Drug Metab Pharmacokinet 25:351-360.
38. Van Aubel R.A., Masereeuw R, and Russel FG (2000) Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol 279:F216-F232.
39. van Praag R.M., Repping S, de Vries JW, Lange JM, Hoetelmans RM, and Prins JM (2001) Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma. Antimicrob Agents Chemother 45:2902-2907.
40. Ward JL, Sherali A, Mo Z.P., and Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter- deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275: 8375-8381.
41. Yao SY, Ng AM, Cass C.E., Baldwin SA, and Young JD (2011) Nucleobase transport by human equilibrative nucleoside transporter 1 (hENT1). J Biol Chem 286: 32552-32562.